Geoffrey M. Parker - 21 Oct 2025 Form 4 Insider Report for Allogene Therapeutics, Inc. (ALLO)

Role: CHIEF FINANCIAL OFFICER
Signature: /s/Earl Douglas, Attorney-in-Fact
Issuer symbol: ALLO
Transactions as of: 21 Oct 2025
Net transactions value: -$46,169
Form type: 4
Filing time: 23 Oct 2025, 18:20:44 UTC
Previous filing: 16 Sep 2025
Next filing: 14 Nov 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Parker Geoffrey M.	CHIEF FINANCIAL OFFICER	210 EAST GRAND AVE, SOUTH SAN FRANCISCO	/s/Earl Douglas, Attorney-in-Fact	23 Oct 2025	0001491874

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ALLO	Common Stock	Sale	$46,169	-36,744	-2.8%	$1.26	1,276,796	21 Oct 2025	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
F2	Pursuant to an employee stock purchase program, includes 6,000 shares of the Issuer's common stock acquired by the reporting person on March 14, 2025 and 6,000 shares of the Issuer's common stock acquired by the reporting person on September 15,2025.

Content

Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Pursuant to an employee stock purchase program, includes 6,000 shares of the Issuer's common stock acquired by the reporting person on March 14, 2025 and 6,000 shares of the Issuer's common stock acquired by the reporting person on September 15,2025.